2020 American Transplant Congress

Saturday, May 30, 2020

10:00am-10:07am

A Multicenter, Randomized, Controlled Trial to Steer Immunosuppressive Therapy by Virus-Specific T Cells after Pediatric Kidney Transplantation (IVIST-Trial)

T. Ahlenstiel-Grunow¹, A. Großhennig¹, R. Schild², J. Oh², C. Taylan³, L. Weber³, H. Staude⁴, M. Verboom¹, C. Schröder¹, R. Sabau¹, A. Koch¹, X. Liu¹, L. Pape¹

Plenary Session I  •  Main Channel

10:10am-10:17am

Crosstalk between TLR4 and HLA Class I Mediates P-Selectin Expression and Monocyte Capture to Endothelial Cells

Y. Jin, N. M. Valenzuela, R. A. Sosa, E. F. Reed

Plenary Session I  •  Main Channel

10:20am-10:27am

Older Organs Transfer Senescence to Transplant Recipients

J. Iske¹, R. Maenosono¹, M. Seyda¹, T. Heinbockel¹, M. Koichiro¹, Y. Nian¹, T. Tchkonia², J. L. Kirkland², R. Abdi¹, A. Elkhal¹, S. G. Tullius¹

Plenary Session I  •  Main Channel

10:30am-10:37am

Direct Acting Anti-Viral Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic Donors to Hepatitis C Negative Kideney Transplant Recipients

G. Gupta, I. Yakubu, D. Kumar, I. Moinuddin, L. Kamal, A. King, C. Bhati, A. Sharma, A. Cotterell, A. Khan, M. Levy, R. Sterling

Plenary Session I  •  Main Channel

3:15pm-3:27pm

A Monocyte-Derived MicroRNA Signature for Antibody-Mediated Rejection in Kidney Transplantation

C. Tinel¹, B. Lamarthée¹, F. Von Tokarski¹, M. Rabant², C. Legendre¹, W. Gwinner³, M. Naesens⁴, P. Marquet⁵, D. Anglicheau¹

Biomarker Discovery and Immune Modulation  •  Virtual

3:15pm-3:27pm

A Multi-Center Pilot and Feasibility Randomized Clinical Trial of a Home-Based Exercise Program for Patients with Cirrhosis: The Strength Training Intervention

J. C. Lai¹, M. R. Kappus², J. L. Dodge¹, R. Wong¹, Y. Mohamad¹, D. L. Segev³, M. A. McAdams-DeMarco⁴

Liver: Portal Hypertension and Other Complications of Cirrhosis  •  Virtual

3:15pm-3:27pm

A Pilot Study of Mkidney: A Novel Mobile Health Platform to Support OPTN Living Donor Follow-Up Data Collection

C. Sidoti¹, W. Zhang¹, M. Waldram¹, A. Thomas¹, M. Levan¹, A. Massie¹, A. Bingaman², R. Forbes³, G. Edwards³, K. Warmke³, K. Centanni³, D. Segev¹, M. Henderson¹

Kidney Living Donor: Other II  •  Virtual

3:15pm-3:27pm

A Prospective Randomized Multicenter Trial (BEST Trial) of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression: Infectious Complications

P. West-Thielke¹, A. Shields², D. Kaufman³, J. Leone⁴, A. Wiseman⁵, A. Matas⁶, T. Sa⁷, E. King⁷, R. Alloway², S. Woodle²

Kidney Infections Excluding Polyoma & Viral Hepatitis  •  Virtual

3:15pm-3:27pm

A Survey of Lung Transplant Recipient Attitudes and Beliefs on Accepting an Organ That Was Positive for Hepatitis C Virus

S. S. Humar¹, N. Pinzon¹, M. Cypel¹, S. Abbey²

Lung: Let's Start at the Beginning: Pre-Transplant Decision Making and Access to Lung Donors  •  Virtual

3:15pm-3:27pm

Accelerated Bronchiolitis Obliterans after Lung Transplant Promoted by the ATG16L1 rs2241880 Mutation is Coupled to Mitochondrial Damage and Metabolic Alterations in Monocyte-Derived Alveolar Macrophages

M. Cano¹, D. Zhou², D. Kreisel³, C. Chen⁴, K. Pugh², D. Byers¹, R. Hachem¹, A. E. Gelman³

Antigen Presentation / Allorecognition / Dendritic Cells  •  Virtual